Search Results - "Peddi, V.R"

Efficacy and Safety of Everolimus Plus Low‐Dose Tacrolimus Versus Mycophenolate Mofetil Plus Standard‐Dose Tacrolimus in De Novo Renal Transplant Recipients: 12‐Month Data by Qazi, Y., Shaffer, D., Kaplan, B., Kim, D. Y., Luan, F. L., Peddi, V. R., Shihab, F., Tomlanovich, S., Yilmaz, S., McCague, K., Patel, D., Mulgaonkar, S.

“…In this 12‐month, multicenter, randomized, open‐label, noninferiority study, de novo renal transplant recipients (RTxRs) were randomized (1:1) to receive…”
Get full text

Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients by BUSQUE, S, LEVENTHAL, J, SLAKEY, D, PEDDI, V. R, FISHER, R. A, LAWENDY, N, WANG, C, CHAN, G, BRENNAN, D. C, STEINBERG, S, KLINTMALM, G, SHAH, T, MULGAONKAR, S, BROMBERG, J. S, VINCENTI, F, HARIHARAN, S

Get full text

Association of Clinical Events With Everolimus Exposure in Kidney Transplant Patients Receiving Low Doses of Tacrolimus by Shihab, F., Qazi, Y., Mulgaonkar, S., McCague, K., Patel, D., Peddi, V. R., Shaffer, D.

“…A key objective in the use of immunosuppression after kidney transplantation is to attain the optimal balance between efficacy and safety. In a phase 3b,…”
Get full text

Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal Function by Marsh, C.L., Kurian, S.M., Rice, J.C., Whisenant, T.C., David, J., Rose, S., Schieve, C., Lee, D., Case, J., Barrick, B., Peddi, V.R., Mannon, R.B., Knight, R., Maluf, D., Mandelbrot, D., Patel, A., Friedewald, J.J., Abecassis, M.M., First, M.R.

“…TruGraf v1 is a laboratory-developed DNA microarray-based gene expression blood test to enable proactive noninvasive serial assessment of kidney transplant…”
Get full text

Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice by First, M.R., Peddi, V.R., Mannon, R., Knight, R., Marsh, C.L., Kurian, S.M., Rice, J.C., Maluf, D., Mandelbrot, D., Patel, A., David, J., Schieve, C., Lee, D., Lewis, P., Friedewald, J.J., Abecassis, M.M., Rose, S.

“…TruGraf v1 is a well-validated DNA microarray-based test that analyzes blood gene expression profiles as an indicator of immune status in kidney transplant…”
Get full text

Polyomavirus in kidney and kidney–pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring by Trofe, J, Cavallo, T, First, M.R, Weiskittel, P, Peddi, V.R, Roy-Chaudhury, P, Alloway, R.R, Safdar, S, Buell, J.F, Hanaway, M.J, Woodle, E.S

Get full text

Malignancies complicating organ transplantation by First, M.R., Peddi, V.R.

Get full text

HLA-identical renal transplant recipients: immunosuppression, long-term complications, and survival by Peddi, V.R., Weiskittel, P., Alexander, J.W., Woodle, E.S., First, M.R.

Get full text

Proteinuria following renal transplantation: Correlation with histopathology and outcome by Peddi, V.R., Dean, D.E., Hariharan, S., Cavallo, T., Schroeder, T.J., First, M.R.

Get full text

Control of risk factors for cardiovascular disease in long-term renal transplant recipients by First, M.R., Peddi, V.R., Weiskittel, P., Woodle, E.S.

Get full text

A comparison of the safety and efficacy of mycophenolate mofetil, prednisone and cyclosporine and mycophenolate mofetil, and prednisone and tacrolimus by Daoud, A.J, Schroeder, T.J, Shah, M, Hariharan, S, Peddi, V.R, Weiskittel, P, First, M.R

Get full text

Long-term outcome in simultaneous kidney and pancreas transplant recipients with functioning allografts at 1-year posttransplantation by Peddi, V.R, Munda, R, Demmy, A.M, First, M.R

Get full text

Recurrent and de novo glomerular disease after renal transplantation: a report from renal allograft disease registry by Hariharan, S, Adams, M.B, Brennan, D.C, Davis, C.L, First, M.R, Johnson, C.P, Ouseph, R, Peddi, V.R, Pelz, C, Roza, A.M, Vincenti, F, George, V

Get full text

Long-term renal and pancreas function with tacrolimus rescue therapy following kidney/pancreas transplantation by Hariharan, S., Peddi, V.R., Munda, R., Demmy, A.M., Schroeder, T.J., Alexander, J.W., First, M.R.

Get full text

Conversion of stable renal transplant recipients from sandimmune to sang-35, a neoral-equivalent cyclosporine formulation, using a dose-adjusted method by First, M.R, Weiskittel, P, Shah, M, Peddi, V.R, Canafax, D, Schroeder, T.J

Get full text

Graft outcome in patients with biopsy-proven chronic renal allograft rejection by Peddi, V.R, Schroeder, T.J, Weiskittel, P, First, M.R

Get full text

Tacrolimus Eliminates Acute Rejection as a Major Complication Following Simultaneous Kidney and Pancreas Transplantation by Peddi, V.R, Demmy, A.M, Munda, R, Alexander, J.W, First, M.R

Get full text

Tacrolimus use in kidney–pancreas recipients is associated with less acute renal dysfunction than cyclosporine by Fleck, P.R, Schroeder, T.J, Dauod, A.J, Peddi, V.R, First, M.R

Get full text

Long-Term Kidney and Pancreas Function With Tacrolimus Immunosuppression Following Simultaneous Kidney and Pancreas Transplantation by Peddi, V.R, Munda, R, Demmy, A.M, Alexander, J.W, First, M.R

Get full text

Efficacy of OKT3 as Primary Therapy for Histologically Confirmed Acute Renal Allograft Rejection in Simultaneous Kidney and Pancreas Transplant Recipients by Peddi, V.R., Kamath, S., Schroeder, T.J., Munda, R., First, M.R.

Get full text